These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7971258)

  • 1. Secondary neoplasms in two patients treated with purine analogues.
    Schlaifer D; Riga-Huguet F; Pris J; Brousset P; Delannoy A; Bosly A
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):341. PubMed ID: 7971258
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC; Ma ES; Kwong YL
    Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Saven A; Lemon RH; Piro LD
    N Engl J Med; 1993 Mar; 328(11):812-3. PubMed ID: 8094889
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse and beneficial immunological effects of purine nucleoside analogues.
    Dighiero G
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S75-81. PubMed ID: 9137960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Waldenstrom's macroglobulinemia with nucleoside analogues.
    Dimopoulos MA; O'Brien S; Kantarjian H; Estey EE; Keating MJ; Alexanian R
    Leuk Lymphoma; 1993; 11 Suppl 2():105-8. PubMed ID: 7907250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second malignancies in chronic lymphocytic leukemia.
    Streu E
    Oncol Nurs Forum; 2014 Jan; 41(1):95-8. PubMed ID: 24368244
    [No Abstract]   [Full Text] [Related]  

  • 7. 2-Chlorodeoxyadenosine therapy in chronic lymphocytic leukemia.
    Saven A; Piro L
    N Engl J Med; 1994 Jun; 330(25):1829-30. PubMed ID: 7910665
    [No Abstract]   [Full Text] [Related]  

  • 8. Current results and prospective trials of cladribine in chronic lymphocytic leukemia.
    Tallman MS; Hakimian D
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):23-7. PubMed ID: 8714613
    [No Abstract]   [Full Text] [Related]  

  • 9. 2-Chlorodeoxyadenosine therapy in chronic lymphocytic leukemia.
    Juliusson G; Liliemark J
    N Engl J Med; 1994 Jun; 330(25):1828-9; author reply 1829-30. PubMed ID: 7910664
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.
    Maddocks-Christianson K; Slager SL; Zent CS; Reinalda M; Call TG; Habermann TM; Bowen DA; Hoyer JD; Schwager S; Jelinek DF; Kay NE; Shanafelt TD
    Br J Haematol; 2007 Nov; 139(3):398-404. PubMed ID: 17910629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia.
    Saven A
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):28-33. PubMed ID: 8714614
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia.
    Del Giudice I; Matutes E; Osuji N; Parry-Jones N; Swansbury J; Catovsky D
    Haematologica; 2005 Feb; 90(2):268-70. PubMed ID: 15710588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells.
    Bouzar AB; Boxus M; Defoiche J; Berchem G; Macallan D; Pettengell R; Willis F; Burny A; Lagneaux L; Bron D; Chatelain B; Chatelain C; Willems L
    Br J Haematol; 2009 Jan; 144(1):41-52. PubMed ID: 19006566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Listeriosis after 2-chlorodeoxyadenosine treatment.
    Spielberger RT; Stock W; Larson RA
    N Engl J Med; 1993 Mar; 328(11):813-4. PubMed ID: 8094890
    [No Abstract]   [Full Text] [Related]  

  • 15. Fludarabine in Waldenstrom's macroglobulinemia.
    Leblond V; Choquet S
    Semin Oncol; 2003 Apr; 30(2):239-42. PubMed ID: 12720144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
    Leleu X; Soumerai J; Roccaro A; Hatjiharissi E; Hunter ZR; Manning R; Ciccarelli BT; Sacco A; Ioakimidis L; Adamia S; Moreau AS; Patterson CJ; Ghobrial IM; Treon SP
    J Clin Oncol; 2009 Jan; 27(2):250-5. PubMed ID: 19064987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders.
    Bowcock SJ; Rassam SM; Lim Z; Ward SM; Ryali MM; Mufti GJ
    Br J Haematol; 2006 Jul; 134(2):242-3. PubMed ID: 16846486
    [No Abstract]   [Full Text] [Related]  

  • 18. New drugs in the treatment of chronic lymphocytic leukemia.
    Keating MJ; O'Brien S; Robertson L; Plunkett W; Kantarjian H; Koller C
    Leukemia; 1992 Nov; 6 Suppl 4():140-1. PubMed ID: 1359203
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ulcers in a patient with chronic lymphocytic leukemia].
    León-Mateos A; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2007 May; 98(4):279-80. PubMed ID: 17506962
    [No Abstract]   [Full Text] [Related]  

  • 20. Reactivation of hepatitis B virus infection during cytotoxic chemotherapy.
    Franceschini R; Cataldi A; Tenconi GL; Icardi G; Bruzzone BM
    Am J Gastroenterol; 2001 Feb; 96(2):606-7. PubMed ID: 11232724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.